---
figid: PMC9332684__pharmaceuticals-15-00914-g005
pmcid: PMC9332684
image_filename: pharmaceuticals-15-00914-g005.jpg
figure_link: /pmc/articles/PMC9332684/figure/pharmaceuticals-15-00914-f005/
number: Figure 5
figure_title: ''
caption: 'Effect of montelukast on renal p-Jak2 and p-STAT3 in a pre-eclampsia model
  in rats. The results show the mean Â± SEM (8 rats/group). (a) Significant (p < 0.05)
  difference from the control group. (b) Significant (p < 0.05) difference from the
  Mont group. (c) Significant (p < 0.05) difference from the L-NAME group. [Mont:
  montelukast; L-NAME: L-NG-Nitro arginine methyl ester; Jak2: Janus kinase 2; STAT3:
  signal transducer and activator of transcription 3].'
article_title: Leukotriene Receptor Antagonist, Montelukast Ameliorates L-NAME-Induced
  Pre-eclampsia in Rats through Suppressing the IL-6/Jak2/STAT3 Signaling Pathway.
citation: Walaa Yehia Abdelzaher, et al. Pharmaceuticals (Basel). 2022 Aug;15(8):914.
year: '2022'

doi: 10.3390/ph15080914
journal_title: Pharmaceuticals
journal_nlm_ta: Pharmaceuticals (Basel)
publisher_name: MDPI

keywords:
- leukotriene receptor antagonist
- L-NAME
- pre-eclampsia
- IL-6/Jak2/STAT3

---
